Publishers

Need unique free news content for your site customized to your audience?

Let's Discuss

By: InvestorBrandNetwork (IBN)
August 27, 2024

InMed Pharmaceuticals (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901

InMed Pharmaceuticals (NASDAQ: INM), a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes from a long-term preclinical study of its Alzheimer’s Disease (“AD”) drug candidate, INM-901. These new findings confirm and expand upon results from a previous short-term pilot study (https://ibn.fm/eASUI). The long-term […]

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is InMed Pharmaceuticals (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901.

{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.